These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 24460473)

  • 21. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In Vitro-In Vivo Correlation in Cocrystal Dissolution: Consideration of Drug Release Profiles Based on Coformer Dissolution and Absorption Behavior.
    Kataoka M; Minami K; Takagi T; Amidon GE; Yamashita S
    Mol Pharm; 2021 Nov; 18(11):4122-4130. PubMed ID: 34618448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In Vitro Assessment of Supersaturation/Precipitation and Biological Membrane Permeation of Poorly Water-Soluble Drugs: A Case Study With Albendazole and Ketoconazole.
    Kataoka M; Takeyama S; Minami K; Higashino H; Kakimi K; Fujii Y; Takahashi M; Yamashita S
    J Pharm Sci; 2019 Aug; 108(8):2580-2587. PubMed ID: 30885658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation and characterization of betulin nanoparticles for oral hypoglycemic drug by antisolvent precipitation.
    Zhao X; Wang W; Zu Y; Zhang Y; Li Y; Sun W; Shan C; Ge Y
    Drug Deliv; 2014 Sep; 21(6):467-79. PubMed ID: 24479653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of the precipitation profiles of weak base drugs in the small intestine using a simplified transfer ("dumping") model coupled with in silico modeling and simulation approach.
    Kambayashi A; Yasuji T; Dressman JB
    Eur J Pharm Biopharm; 2016 Jun; 103():95-103. PubMed ID: 27012902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ketoconazole ion-exchange fiber complex: a novel method to reduce the individual difference of bioavailability in oral administration caused by gastric anacidity.
    Xin C; Li-hong W; Jing Y; Yang Y; Yue Y; Qi-fang W; San-ming L
    Pharm Dev Technol; 2013; 18(6):1346-54. PubMed ID: 22670853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integration of Precipitation Kinetics From an In Vitro, Multicompartment Transfer System and Mechanistic Oral Absorption Modeling for Pharmacokinetic Prediction of Weakly Basic Drugs.
    Patel S; Zhu W; Xia B; Sharma N; Hermans A; Ehrick JD; Kesisoglou F; Pennington J
    J Pharm Sci; 2019 Jan; 108(1):574-583. PubMed ID: 30395833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Revisiting Supersaturation of a Biopharmaceutical Classification System IIB Drug: Evaluation via a Multi-Cup Dissolution Approach and Molecular Dynamic Simulation.
    Gan Y; Xu Y; Zhang X; Hu H; Xiao W; Yu Z; Sun T; Zhang J; Wen C; Zheng S
    Molecules; 2023 Oct; 28(19):. PubMed ID: 37836805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
    Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Supersaturation of zafirlukast in fasted and fed state intestinal media with and without precipitation inhibitors.
    Madsen CM; Boyd B; Rades T; Müllertz A
    Eur J Pharm Sci; 2016 Aug; 91():31-9. PubMed ID: 27260089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of an In Vitro Dissolution/Permeation System to Early Screening of Oral Formulations of Poorly Soluble, Weakly Basic Drugs Containing an Acidic pH-Modifier.
    Mizoguchi M; Kataoka M; Yokoyama K; Aihara R; Wada K; Yamashita S
    J Pharm Sci; 2018 Sep; 107(9):2404-2410. PubMed ID: 29802932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. pH-dependent dissolution in vitro and absorption in vivo of weakly basic drugs: development of a canine model.
    Zhou R; Moench P; Heran C; Lu X; Mathias N; Faria TN; Wall DA; Hussain MA; Smith RL; Sun D
    Pharm Res; 2005 Feb; 22(2):188-92. PubMed ID: 15783065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Self-microemulsifying drug delivery system for improved oral bioavailability of dipyridamole: preparation and evaluation.
    Guo F; Zhong H; He J; Xie B; Liu F; Xu H; Liu M; Xu C
    Arch Pharm Res; 2011 Jul; 34(7):1113-23. PubMed ID: 21811918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Precipitation in and supersaturation of contents of the upper small intestine after administration of two weak bases to fasted adults.
    Psachoulias D; Vertzoni M; Goumas K; Kalioras V; Beato S; Butler J; Reppas C
    Pharm Res; 2011 Dec; 28(12):3145-58. PubMed ID: 21674262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro-in silico-in vivo approach.
    Fei Y; Kostewicz ES; Sheu MT; Dressman JB
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1274-84. PubMed ID: 23500116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predicting the precipitation of poorly soluble weak bases upon entry in the small intestine.
    Kostewicz ES; Wunderlich M; Brauns U; Becker R; Bock T; Dressman JB
    J Pharm Pharmacol; 2004 Jan; 56(1):43-51. PubMed ID: 14980000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastrointestinal dissolution, supersaturation and precipitation of the weak base indinavir in healthy volunteers.
    Rubbens J; Brouwers J; Tack J; Augustijns P
    Eur J Pharm Biopharm; 2016 Dec; 109():122-129. PubMed ID: 27693678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved dissolution and absorption of ketoconazole in the presence of organic acids as pH-modifiers.
    Adachi M; Hinatsu Y; Kusamori K; Katsumi H; Sakane T; Nakatani M; Wada K; Yamamoto A
    Eur J Pharm Sci; 2015 Aug; 76():225-30. PubMed ID: 25988287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantifying In Vivo Luminal Drug Solubilization -Supersaturation-Precipitation Profiles to Explain the Performance of Lipid Based Formulations.
    Tanaka Y; Tay E; Nguyen TH; Porter CJH
    Pharm Res; 2020 Feb; 37(3):47. PubMed ID: 32016597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Precipitation in the small intestine may play a more important role in the in vivo performance of poorly soluble weak bases in the fasted state: case example nelfinavir.
    Shono Y; Jantratid E; Dressman JB
    Eur J Pharm Biopharm; 2011 Oct; 79(2):349-56. PubMed ID: 21527341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.